Generics 6

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Aciclovir manufacturers

6 products found

Filters

Filters

Filters , active

Country of origin : Spain

Clear all

6 products found

aciclovir

Vials, injection 250mg - 10ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Czech Republic
Manufacturer #651
This company is a pharmaceutical entity established in Europe over 90 years ago. They are publicly traded and have a diverse portfolio of prescription and over-the-counter (OTC) medications, as well as food supplements. Their key areas of focus include **cardiology, oncology, and central nervous system (CNS)**, while producing a wide range of dosage forms, including solids, liquids, and injectables. This company also specializes in Contract Development and Manufacturing (CDMO) and Contract Manufacturing (CMO) services, which are offered to other pharmaceutical companies. They have production facilities in Europe with EU GMP approvals. The company has a global presence, with operations in various regions, including Europe, North America, and Asia.

Manufacturer usually replies in 7 days

aciclovir

Vials, lyophilized injection 250 mg - 10 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Albania , Belgium , Bosnia And Herzegovina , Germany , Italy , Kosovo , North Macedonia , Montenegro , Netherlands , Serbia , United Kingdom , Vietnam
Registered in
Belgium , Germany , Italy , Netherlands , Spain , United Kingdom
Manufacturer #15084
This European pharmaceutical company specializes in the Central Nervous System (CNS) and Hospital Injectables. They operate in a niche market focusing on treatments for debilitating conditions like chronic pain and addiction. With a strong commitment to patient care, they are actively seeking new opportunities to expand their product portfolio and geographical reach, particularly within the EU market. Their core therapy areas include CNS disorders, pain management, and addiction treatment. The company has a robust research and development (R&D) program and actively seeks strategic partnerships to further its growth. This company develops and produces both prescription and over-the-counter (OTC) medications in various dosage forms, including injectables, solids, and liquids, which are manufactured under EU and other GMP standards. They hold numerous patents for their innovative drug formulations and have a track record of successful acquisitions, demonstrating their commitment to expanding their presence in the pharmaceutical industry. This company has a solid presence in the European market with an expansion into the Asia region, and is actively pursuing opportunities to expand its global footprint.

Manufacturer usually replies in 18 days

aciclovir

Ointment 5 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Zovirax®
Manufacturer #252
This company is a leading player in the pharmaceutical industry, boasting decades of experience in research, development, and manufacturing. They specialize in the production of a wide range of pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) for both human and veterinary use. Their product portfolio spans multiple therapeutic areas, including but not limited to, oncology, cardiology, and other essential therapeutic categories. They offer a comprehensive range of services, including contract manufacturing (CMO) and the production of over-the-counter (OTC) products. The company holds EU and US GMP approvals for its production lines, ensuring adherence to rigorous quality standards. Their production lines encompass various dosage forms, including solids, liquids, and injectables. Their global presence extends across Europe and North America, with a network of 10 manufacturing facilities. They have a strong commitment to research and development, with dedicated teams focusing on innovative solutions and advancements in the pharmaceutical field.

Manufacturer usually replies in 12 days

Want to see all 6 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Aciclovir:

Also known as acyclovir, it is an antiviral drug first manufactured in the 1970s and subsequently approved for use in the medical field in the 1980s for the treatment of most infections caused by the herpesvirus family. This was followed by the closely related prodrug form, valaciclovir, which came into medicinal use in 1995, being transformed in the body to aciclovir after absorption. In 2009 the combination of aciclovir with hydrocortisone cream, marketed as Xerese, was approved for medicinal use in the United States for the treatment of herpes labialis (cold sores). Currently, aciclovir is on the World Health Organization’s List of Essential Medicines, indicating its central role as a safe and cost efficient medication in health systems across the globe. Although initially patented, it has since expired and thus it is for sale under numerous names, including Cymex Ultra, Zovirax and Virasorb. Where it is primarily used in the treatment of herpes, chickenpox, and shingles infections. Additionally, it is also known to be effective for the prevention of both transplant induced cytomegalovirus infections and those caused by the Epstein-Barr virus.

Method of action

Aciclovir belongs to the pharmacotherapeutic group of drugs consisting of direct acting antiviral nucleosides and nucleotides excl. Functioning in the inhibition of reverse transcriptase, a vital process in which infections such as the herpes simplex virus rely upon to reverse transcribe their RNA into DNA, facilitating replications and subsequent disease spread.

Form and dosage

The intake method is dependent on the aciclovir manufacturer’s and aciclovir supplier’s chosen packaging, with availability being common in tablet, liquid, and cream forms. Capable of being taken orally as a suspension solution or a capsule, as well as topically as an ointment. Specific dosages for tablet and liquid forms are illness dependent, however they typically vary between 200mg and 800mg, with lower values for children. These are taken 2 to 5 times a day, with or without food, and it is advised to stay well hydrated as kidneys are taxed by the medication. The use of creams is similar, with 5 applications of a thin layer applied each day.

Aciclovir on Pipelinepharma

As with most pharmaceutical products which have become generic, aciclovir is available on the global marketplace from a variety of suppliers, distributors, and wholesalers. An online search on our company Pipelinepharma.com website reveals, at the current time of writing, a list of over 90 verified global aciclovir manufacturers and aciclovir suppliers available for B2B order and negotiation online. This product is for sale from manufacturers in a wide variety of countries including the European Union, India, Turkey, Ukraine, Brazil, Jordan, Colombia, China, South Korea, Malaysia, Egypt, Lebanon, Thailand, Argentina, and Kuwait.

Price of aciclovir and how to buy

Although official company statistics on price cannot be disclosed due to their confidential and negotiable nature. Aciclovir typically remains both potent and cost effective, not requiring any specific brand licensing to reproduce. This facilitates convenience for buyers looking to source both manufacturers and suppliers, which can be easily done through the online search function of the Pipelinepharama’s marketplace. Displaying a list of trusted vendors which have been vetted under strict quality control measures.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible